Choreo LLC’s Idexx Laboratories IDXX Stock Holding History

Choreo LLC’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	2,030 +36	+2%	+$23.1K	0.01%	567
2025 Q4	$1.36M	Sell	1,994 -672	-25%	-$458K	0.02%	488
2025 Q3	$1.7M	Sell	2,666 -21	-0.8%	-$12.7K	0.02%	410
2025 Q2	$1.44M	Buy	2,687 +1,143	+74%	+$547K	0.02%	455
2025 Q1	$648K	Buy	1,544 +64	+4%	+$27.8K	0.01%	717
2024 Q4	$611K	Sell	1,480 -476	-24%	-$209K	0.01%	798
2024 Q3	$969K	Sell	1,956 -613	-24%	-$298K	0.01%	585
2024 Q2	$1.23M	Buy	+2,569	New	+$1.29M	0.02%	447
2015 Q2	–	Sell	-3,000	Closed	-$232K	–	155
2015 Q1	$232K	Hold	3,000	–	–	0.06%	132
2014 Q4	$222K	Buy	+3,000	New	+$210K	0.06%	135
2014 Q3	–	Sell	-3,000	Closed	-$200K	–	151
2014 Q2	$200K	Buy	+3,000	New	+$191K	0.06%	142

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Choreo LLC's IDXX Position: Q1 2026 in Review

Choreo LLC increased its Idexx Laboratories (IDXX) stake by 1.8% in Q1 2026, buying an estimated $23.1K and bringing the position to 2,030 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #567.

Choreo LLC first reported a position in IDXX in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.7M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Choreo LLC held 2,030 shares of Idexx Laboratories worth $1.14M as of Q1 2026.
Choreo LLC bought 36 Idexx Laboratories shares in Q1 2026, an estimated $23.1K.
Idexx Laboratories made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #567 holding.
Choreo LLC first reported a position in Idexx Laboratories in Q2 2014 and has held it in 11 quarters since.
Choreo LLC's Idexx Laboratories position peaked at $1.7M in Q3 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.